Food News and Research

RSS

Study finds possible link between ghrelin hormone and hedonic eating

When eating is motivated by pleasure, rather than hunger, endogenous rewarding chemical signals are activated which can lead to overeating, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

3 May 2012

Biosynthetic polyphenol improves cognitive function in mice with AD

Mount Sinai School of Medicine researchers have succeeded in developing a biosynthetic polyphenol that improves cognitive function in mice with Alzheimer's disease.

3 May 2012

Physician Therapeutics publishes results from Sentra PM clinical trial

Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that manufactures and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the proprietary medical food Sentra PM.

3 May 2012

XenoPort first quarter revenues increase to $10.4 million

XenoPort, Inc. announced today its financial results for the first quarter ended March 31, 2012. Revenues for the quarter were $10.4 million, compared to $0.4 million for the same period in 2011.

3 May 2012

EKOS launches two landmark clinical studies on pulmonary embolism

EKOS Corporation today announced the launch of two more landmark clinical studies named SEATTLE I & II, intended to further establish the safety and efficacy of its unique, ultrasound-accelerated thrombolysis in treating patients with life-threatening pulmonary embolism.

3 May 2012

Arena's first quarter net loss decreases to $29.4 million

Arena Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2012, and reviewed recent developments.

2 May 2012

FDA approval of TDF/FTC as PrEP for HIV infection receives support

In public comments submitted this week, a group of 14 leading HIV/AIDS and health organizations stated their support for Food and Drug Administration (FDA) approval of emtricitabine/ tenofovir disoproxil fumarate (TDF/FTC or Truvada) as pre-exposure prophylaxis (PrEP) to prevent HIV infection in adult men and women.

2 May 2012

Optimum blood vitamin D levels to reduce risk of major medical events

In testing older patients' blood vitamin D levels, there's uncertainty about where the dividing line falls between enough and not enough. The threshold amount has become controversial as several scientific societies set different targets.

2 May 2012

It's never too late to take control of diabetes

"You could live a normal life." Those were the words that 15-year-old Steve Edelman kept hearing from the nurses when he was hospitalized following his type 1 diabetes diagnosis in 1970. He wondered why they kept repeating this to him.

2 May 2012

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Mount Sinai School of Medicine researchers have succeeded in developing a biosynthetic polyphenol that improves cognitive function in mice with Alzheimer's disease (AD). The findings, published in a recent issue of the Journal of Neuroscience, provide insight in determining the feasibility of biosynthetic polyphenols as a possible therapy for AD in humans, a progressive neurodegenerative disease for which there is currently no cure.

2 May 2012

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.

2 May 2012

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

ImmuVen was awarded a Phase II Small Business Innovation Research (SBIR) grant totaling $1.68 million from the National Institute for Allergy and Infectious Disease (NIH) for continuing development of its therapeutic pipeline (IMV0123) against superantigens produced by methicillin-sensitive and methicillin-resistant Staphylococcal aureus.

2 May 2012

Blood services workers on strike in Michigan, Ohio

The American Red Cross is viciously attacking its workforce in the Midwest. More than 300 qualified, hardworking unionized blood services workers remain on strike over plans by Red Cross that would destabilize blood supply safety and strip workers of their collective bargaining rights.

2 May 2012

FDA permits Percutaneous Surgical Set for minimally invasive laparoscopic abdominal surgery

On April 30, the U.S. Food and Drug Administration today allowed marketing of the first surgical instrument set that can be assembled and disassembled inside the body during surgery.

2 May 2012

Lower rate of reintubation observed in infants receiving SURFAXIN

Discovery Laboratories, Inc. today announced the presentation of a new pharmacoeconomic analysis demonstrating that the lower rate of reintubation previously reported in infants treated with SURFAXIN, when compared with infants treated with Curosurf® and Survanta®, the current global market leading surfactants, also resulted in a potential hospital cost savings of $160,000 to $252,000 per 100 infants.

2 May 2012

Dixie announces new hemp-based Cannabidiol products without THC

Dixie Elixirs and Edibles, Colorado's premier Tetrahydrocannabinol or THC-infused products company, today announced a new line of products which will break entirely new ground for the company in the category of non-THC-infused product development.

2 May 2012

Biogen Idec first quarter revenues increase 7% to $1.3 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its first quarter 2012 results.

2 May 2012

3M Health Care honored with Silver Edison Awards

Today, 3M Health Care announced it has been honored with a Silver Edison Award for Quality of Life in the Lifestyle and Social Impact category for its 3M™ Kind Removal Silicone Tape and a Silver Edison Award for Analytic Systems in the Science/Medical category for its Aerobic Procedure for Lactic Acid Bacteria with 3M Petrifilm Aerobic Count Plate. The Edison Awards, established in 1987, recognize the most innovative products in the world.

2 May 2012

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

Pfizer Inc. and Protalix BioTherapeutics, Inc. announced today that the United States (U.S.) Food and Drug Administration (FDA) approved ELELYSO (taliglucerase alfa) for injection, an enzyme replacement therapy (ERT) for the long-term treatment of adults with a confirmed diagnosis of type 1 Gaucher disease.

2 May 2012

Teleflex strengthens Anesthesia product portfolio

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, announced it has acquired the EZ-BlockerTM disposable catheter product line with a unique bifurcated distal end, a novel and patented bronchial blocker for lung isolation and one-lung ventilation.

2 May 2012